Termination by a Party. If either party decides to withdraw from the Collaborative Process, the party shall give prompt written notice to the other party or Team members. Such notice may be given through his or her attorney. Such withdrawal by a party terminates the Collaborative Process. Upon such withdrawal, in order to provide the other party the opportunity to retain another attorney and make an orderly transition, there will be a thirty (30) day period (unless there is an emergency) before either party files any pleading or motion with, or otherwise makes any request to, a court,. During this thirty (30) day period, all temporary agreements, even if unsigned, set forth in approved Minutes, and the parties’ agreement herein to preserve the status quo, will remain in full force and effect. The intent of this provision is to avoid surprise and prejudice to the rights of the other party. It is therefore mutually agreed that either party may bring this provision to the attention of the Court in requesting a postponement of a hearing, or dismissing the case, or ensuring that the terms of temporary agreements and the parties’ status quo agreement are followed during the thirty (30) day period. In the event that a party terminates the Process under 9.A(ii) or (iii), the other party is not bound by the waiting period described herein.
Termination by a Party. Any Operator Party may terminate its participation in this Agreement with immediate effect by written notice served on each of the other Parties if that Party becomes aware that a Quality Contract Scheme is being considered by any of the CA, Nexus, the Local Authorities or if any steps are taken in any area, or part of an area covered by this Agreement (or an area substantially similar to it), to implement a Quality Contract Scheme.
Termination by a Party. Any Party may terminate this MOU by giving written notice to the other Party.
Termination by a Party. Either party may terminate this Support Agreement as follows:
Termination by a Party. Notwithstanding anything contained herein to the contrary, after the Research Program has ended or been terminated and if no IRCT Compounds are being sold as Products and no IRCT Compounds are in development, MERCK shall have the right to terminate this Agreement at any time in its sole discretion by giving ninety (90) days’ advance written notice to deCODE. Not later than thirty (30) days after the date of such termination, each Party shall return or cause to be returned to the other Party all Information in tangible form received from the other party and all copies thereof, except that each party may retain one copy in its confidential files for records purposes. In the event of termination under this Section 8.2: (i) each Party shall pay all amounts then due and owing as of the termination date; and (ii) except for the surviving provisions set forth in Section 8.4 hereof, the rights and obligations of the parties hereunder shall terminate as of the date of such termination; PROVIDED, HOWEVER, that MERCK retain all licenses granted under Section 3.1 in the scope that existed immediately prior to termination.
Termination by a Party. Notwithstanding Section 6.1, this Agreement may be terminated by written notice of termination given by a Party to the other Party if any of the following events occur:
Termination by a Party. This Agreement may be terminated at any time prior to the Closing by either Party (the “Non-Breaching Party”) by giving written notice to the other Party (the “Breaching Party”) if (a) there has been a breach by the Breaching Party of any agreement, covenant, representation or warranty contained in this Agreement, which breach shall not have been cured to the satisfaction of the Non-Breaching Party prior to the Closing, or (b) the Closing does not occur on or prior to the Closing Date.
Termination by a Party. In the case of material breach, the non-breaching Party shall have the right to terminate this Agreement, by written notice specifying the breach or default, if the Party is in breach or default of a material provision of this Agreement, and fails to cure such breach or default within sixty (60) days of receipt of written notice of such breach or default, or fails to commence, within sixty (60) days of such written notice, a cure of any such breach or default which requires more than sixty (60) days to cure, or thereafter fails to diligently pursue such cure to completion. If, however, the Party alleged to be in breach or default notifies the other Party in writing that it disputes the asserted breach or default, any such termination shall not become effective unless the breaching Party fails to cure any such breach or default within sixty (60) days following the final resolution of such dispute. The breach or default by one Party in the performance of any of its material obligations shall not relieve the other Party of its obligation to perform under this Agreement, unless the non-breaching Party terminates this Agreement as provided in this paragraph 9.2.
Termination by a Party. (a) Novartis may terminate this Agreement at any time after [***] days’ prior written notice to SGX, in the event that Novartis *** Confidential Treatment Request reasonably determines that further development of any and all Collaboration Compounds and Product(s) is not viable for competitive, efficacy or safety reasons.
Termination by a Party. This Agreement may be terminated by either party at any time upon 60 days written notice to the other party. Upon the appointment of a replacement custodian by the Client, the Securities Firm shall have a reasonable time to transfer the Securities and Property, along with records pertaining to the Securities and Property, to the new custodian, in accordance with the written instructions of the Client, the Commissioner, or the person or entity legally entitled to receive such Securities and Property.
